EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Carna Biosciences's enterprise value is 円3,613 Mil.
Carna Biosciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was 円1,580 Mil. Therefore, Carna Biosciences's EV-to-Revenue for today is 2.29.
The historical rank and industry rank for Carna Biosciences's EV-to-Revenue or its related term are showing as below:
TSE:4572'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.5 Med: 10.41 Max: 39.88
Current: 2.29
During the past 13 years, the highest EV-to-Revenue of Carna Biosciences was 39.88. The lowest was 1.50. And the median was 10.41.
TSE:4572's EV-to-Revenue is ranked better than 78.25% of 1039
companies
in the Biotechnology industry
Industry Median: 8.18
vs TSE:4572: 2.29
The historical data trend for Carna Biosciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Carna Biosciences's EV-to-Revenue
For the Biotechnology subindustry, Carna Biosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carna Biosciences's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Carna Biosciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Carna Biosciences's EV-to-Revenue falls into.
Carna Biosciences's current Enterprise Value is 円3,613 Mil.
Carna Biosciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,580 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carna Biosciences's share price for today is 円388.00.
Carna Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円92.18.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carna Biosciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Carna Biosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Carna Biosciences, Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines primarily for the treatment of cancer and inflammatory diseases using own innovative kinase drug discovery platform, QuickScout.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4572 has been successfully added to your 